UK markets close in 5 hours

Astrana Health, Inc. (3AM.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
36.20+1.40 (+4.02%)
As of 09:59AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.65B
Enterprise value 1.74B
Trailing P/E 28.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.21
Price/book (mrq)2.60
Enterprise value/revenue 1.29
Enterprise value/EBITDA 14.04

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 316.00%
S&P500 52-week change 326.43%
52-week high 341.60
52-week low 327.00
50-day moving average 336.89
200-day moving average 334.77

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 545.44M
Implied shares outstanding 647.52M
Float 834.74M
% held by insiders 123.03%
% held by institutions 140.41%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.29%
Operating margin (ttm)7.45%

Management effectiveness

Return on assets (ttm)5.19%
Return on equity (ttm)12.23%

Income statement

Revenue (ttm)1.45B
Revenue per share (ttm)31.07
Quarterly revenue growth (yoy)19.90%
Gross profit (ttm)N/A
EBITDA 110.27M
Net income avi to common (ttm)62.42M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)13.00%

Balance sheet

Total cash (mrq)337.29M
Total cash per share (mrq)7.11
Total debt (mrq)433.57M
Total debt/equity (mrq)95.83%
Current ratio (mrq)1.52
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A